Table 2.
Clinicopathologic characteristics resected patients
| Variable | n=25 | |
|---|---|---|
|
| ||
| Age, median years [IQR] | 66 | [60, 73] |
|
| ||
| Male, n (%) | 16 | 64% |
|
| ||
| Neoadjuvant regimen | ||
| FOLFIRINOX | 22 | 88% |
| Gemcitabine and Nab-Paclitaxel | 1 | 4% |
| Multiple/Other | 2 | 8% |
|
| ||
| Prior exploration | 3 | 12% |
|
| ||
| Surgery type | ||
| Pancreaticoduodenectomy | 18 | 72% |
| Distal pancreatectomy | 7 | 28% |
|
| ||
| Vascular resection | 14 | 56% |
| Venous resection | 10 | 40% |
| Arterial resection or divestment | 9 | 36% |
| Both arterial and venous | 5 | 20% |
|
| ||
| ISGPS duct size | ||
| ≤3mm | 4 | 22% |
| >3mm | 14 | 78% |
|
| ||
| T stage | ||
| ypT1 | 4 | 18% |
| ypT2 | 13 | 59% |
| ypT3 | 3 | 14% |
| ypT4 | 2 | 9% |
|
| ||
| Nodal stage | ||
| N0 | 17 | 71% |
| N1 | 6 | 25% |
| N2 | 1 | 4% |
| Perineural invasion | 15 | 63% |
|
| ||
| Lymphovascular invasion | 13 | 57% |
|
| ||
| R0 resection | 17 | 71% |
|
| ||
| CAP Regression score | ||
| 0–1 | 4 | 17% |
| 2 | 11 | 46% |
| 3 | 9 | 37% |
|
| ||
| Pancreatic fistula grade B, C | 0 | 0% |